Helix BioPharma Corp. (TSX:HBP)
Canada · Delayed Price · Currency is CAD 1.840
-0.010 (-0.54%)
At close: Feb 10, 2026
Helix BioPharma Employees
Helix BioPharma had 7 employees as of July 31, 2024. The number of employees decreased by 2 or -22.22% compared to the previous year.
Employees
7
Change (1Y)
-2
Growth (1Y)
-22.22%
Revenue / Employee
n/a
Profits / Employee
-696.71K CAD
Market Cap
140.54M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jul 31, 2024 | 7 | -2 | -22.22% |
| Jul 31, 2023 | 9 | 2 | 28.57% |
| Jul 31, 2022 | 7 | -3 | -30.00% |
| Jul 31, 2021 | 10 | -1 | -4.76% |
| Jul 31, 2020 | 11 | -8 | -41.67% |
| Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Eupraxia Pharmaceuticals | 33 |
| Medicenna Therapeutics | 18 |
| Satellos Bioscience | 17 |
| BriaCell Therapeutics | 16 |
| Sernova Biotherapeutics | 8 |
Helix BioPharma News
- 6 days ago - Helix Biopharma Corp. Extends LEUMUNA Option with metaShape Pharma for Adipose Tissue-Related and Metabolic Diseases - TheNewswire
- 12 days ago - Helix BioPharma Corp. Announces Voting Results from its Annual General and Special Meeting - TheNewswire
- 2 months ago - Helix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Three-Month Period Ended October 31, 2025 - TheNewswire
- 3 months ago - Helix Biopharma GAAP EPS of -$0.09 - Seeking Alpha
- 3 months ago - Helix BioPharma Corp. Announces Fiscal 2025 Year-End Results - TheNewswire
- 4 months ago - Helix BioPharma Responds to Market Activity - TheNewswire
- 5 months ago - Helix BioPharma Announces Presentation at Q3 Investor Summit Virtual on 16 September 2025 - TheNewswire
- 5 months ago - Helix BioPharma Concludes Review, Will Not Proceed with Proposed Equity Draw-Down Subscription Facility with GEM - TheNewswire